SMTL ID : 7jut.1

Crystal Structure of KSR2:MEK1 in complex with ANP-PNP, and allosteric MEK inhibitor Selumetinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.09 Å

Oligo State

hetero-1-1-mer

Ligands

2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 19 residues within 4Å: Chain A: I.64, G.65, K.66, G.67, R.68, F.69, V.72, A.82, R.84, S.132, L.133, C.134, T.138, K.180, K.182, N.183, F.185, D.195, Q.217 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:R.68, A:R.68, A:R.68, A:F.69, A:S.132, A:C.134, A:K.182, A:N.183, A:D.195, A:Q.217 Salt bridges: A:R.84 ANP.2: 16 residues within 4Å: Chain A: K.213 Chain B: L.65, V.73, K.88, M.134, E.135, H.136, M.137, S.141, Q.144, K.183, S.185, N.186, L.188, D.199 Ligands: 3EW.3 11 PLIP interactions: 2 interactions with chain A, 9 interactions with chain B Hydrogen bonds: A:K.213, A:K.213, B:E.135, B:M.137, B:S.141, B:S.141, B:S.141, B:K.183, B:S.185, B:S.185 Salt bridges: B:K.88

1 x 3EW: 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide(Non-covalent)

3EW.3: 13 residues within 4Å: Chain B: K.88, L.106, L.109, V.118, I.132, M.134, D.199, F.200, V.202, S.203, L.206, I.207 Ligands: ANP.2 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:L.109, B:F.200 Hydrogen bonds: B:K.88, B:V.202, B:S.203 Halogen bonds: B:V.118

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Khan, Z.M. et al., Structural basis for the action of the drug trametinib at KSR-bound MEK. Nature (2020)

Release Date

2020-09-30

Peptides

Kinase suppressor of Ras 2: A
Dual specificity mitogen-activated protein kinase kinase 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
C

Kinase suppressor of Ras 2

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence